Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Doloteffin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
In a retrospective evaluation of patients taking part for 2 months in a postmarketing surveillance study on the effectiveness and… Expand
2007
2007
We recruited 114 patients (56 with chronic nonspecific low back pain, 37 with osteoarthritic knee and 21 with osteoarthritic hip… Expand
2005
2005
OBJECTIVE To complete a year's follow-up on patients from a 6-week double-blind pilot comparison between 44 Doloteffin patients… Expand
Review
2004
Review
2004
Preparations from devil's claw differ in their content of active ingredients as assessed by the quantity of harpagoside present… Expand
2004
2004
ZusammenfassungPräparate aus der Teufelskrallenwurzel unterscheiden sich beträchtlich hinsichtlich ihres Gehalts an… Expand
Highly Cited
2003
Highly Cited
2003
OBJECTIVE This randomized, double-dummy, double-blind pilot study of acutely exacerbated low back pain was aimed to inform a… Expand
Highly Cited
2003
Highly Cited
2003
Preparations made from the secondary tubers of Devil's claw (Harpagophytum procumbens) are successfully used in patients with… Expand
Review
2003
Review
2003
OBJECTIVE To examine systematically the quality of the clinical trials investigating the effectiveness of Harpagophytum products… Expand
Highly Cited
2002
Highly Cited
2002
Besides checking estimates of effectiveness and safety of using the proprietary Harpagophytum extract Doloteffin, this… Expand
2002
2002
Objective. This randomized, double-dummy, double-blind pilot study of acutely exacerbated low back pain was aimed to inform a… Expand
  • table 1
  • figure 1
  • table 3
  • table 2
  • table 4